The investigation of immunoligical and molecular mecahanisms between obsessive-compulsive disorder and its comorbidity.

The investigation of immunoligical and molecular mecahanisms between obsessive-compulsive disorder and its comorbidity. - The investigation of immunoligical and molecular mecahanisms between obsessive-compulsive disorder and its comorbidity.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046381

Enrollment

200

Registered

2022-04-01

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obsessive-compulsive disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who have been diagnosed with obsessive-compulsive disorder based on the 5th edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Psychiatric Disorders, who are in the Department of Psychiatry and Neurology, Hyogo Medical University Hospital, have diagnostic criteria for autism spectrum disorder. Those who meet, those who meet the diagnostic criteria for obsessive-compulsive disorder, and those who meet the diagnostic criteria for tic disorder or Tourette's disorder. In addition, the person who can understand the purpose of this study by the attending physician, is judged to be able to participate, and has given free will consent in writing. Those who have been admitted to the Department of Psychiatry and Neurology, Hyogo College of Medicine Hospital, and have been diagnosed with compulsive disorder based on the 5th edition of the American Psychiatric Association's Psychiatric Disorder Diagnosis and Statistics Manual, and other mental disorders. Those who do not meet the diagnostic criteria. In addition, the person who can understand the purpose of this study by the attending physician, is judged to be able to participate, and has given free will consent in writing.

Exclusion criteria

Exclusion criteria: Those who do not get consent, those who the attending physician admits that there is a problem with consent ability, those who admit significant excitement, violence, drug dependence / abuse, patients with severe heart failure, liver failure, etc.

Design outcomes

Primary

Measure	Time frame
Cytokines	—

Countries

Japan

Contacts

Public ContactKyosuke Yamanishi

HYOGO MEDICAL UNIVERSITY Department of Psychiatry

k-yama@hyo-med.ac.jp0798456111

Outcome results